These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 2183476)

  • 1. [Epidemiology of atherosclerosis and disorders of lipid metabolism].
    Kunze M; Schwarz B
    Wien Med Wochenschr; 1990 Feb; 140(4):94-100. PubMed ID: 2183476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.
    Singh RB; Rastogi SS; Rao PV; Das S; Madhu SV; Das AK; Sahay BK; Fuse SM; Beegom R; Sainani GS; Shah NA
    J Cardiovasc Risk; 1997 Jun; 4(3):201-8. PubMed ID: 9475675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of hyperlipidemia in Austria].
    Schwarz B; Kunze M
    Wien Med Wochenschr; 1994; 144(12-13):290-2. PubMed ID: 8650931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A 20-year prospective study on risk factors for myocardial infarction of 5,137 men in Capital Steel and Iron Company].
    Yue H; Gu DF; Wu XG; Yu XH; Duan XF; Wang JH; Zheng RP; Zhou J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):43-6. PubMed ID: 14989905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The validity of the separate determination of total cholesterol in the primary prevention of coronary risk].
    Gil VF; Rubio C; Belda J; Pascual R; Pérez Barba C; Merino J
    Med Clin (Barc); 1995 Apr; 104(16):612-6. PubMed ID: 7752712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Göttingen Risk, Incidence and Prevalence (GRIPS) study. Recommendations for the prevention of coronary heart disease].
    Cremer P; Muche R
    Ther Umsch; 1990 Jun; 47(6):482-91. PubMed ID: 2375005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors as prognostic factors of hospital mortality in patients with acute myocardial infarction].
    Ivanusa M; Milicić D; Bozikov J; Ivanusa Z
    Acta Med Croatica; 2007 Jun; 61(3):307-13. PubMed ID: 17629107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the prevention of coronary artery disease in Asians: a scientific statement of the International College of Nutrition.
    Singh RB; Mori H; Chen J; Mendis S; Moshiri M; Zhu S; Kim SH; Sy RG; Faruqui AM
    J Cardiovasc Risk; 1996 Dec; 3(6):489-94. PubMed ID: 9100083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid lowering treatment in secondary prevention following myocardial infarct].
    Paragh G; Balogh Z; Boda J; Mohácsi A; Kovács P; Polgár P; Wórum F; Kakuk G
    Orv Hetil; 1997 Jul; 138(29):1849-53. PubMed ID: 9280882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.